• 1. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 5. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoyl derivatives

Introduction to 4-Chloro-3,5-difluorobenzaldehyde (CAS No. 1160573-20-5)

4-Chloro-3,5-difluorobenzaldehyde, with the chemical formula C?H?ClF?O and CAS number 1160573-20-5, is a fluorinated aromatic aldehyde that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound belongs to a class of molecules characterized by the presence of both chlorine and fluorine substituents on a benzene ring, which imparts unique electronic and steric properties. The aldehyde functional group at the 1-position further enhances its reactivity, making it a valuable intermediate in synthetic chemistry.

The synthesis and applications of 4-Chloro-3,5-difluorobenzaldehyde have been extensively studied due to its potential in drug discovery and material science. The introduction of fluorine atoms into aromatic systems is well-known for improving metabolic stability, lipophilicity, and binding affinity to biological targets. In particular, the combination of chlorine and fluorine provides a versatile platform for further functionalization, enabling the construction of more complex molecules.

In recent years, 4-Chloro-3,5-difluorobenzaldehyde has been explored as a key intermediate in the development of novel therapeutic agents. Its structural features make it an attractive building block for designing small-molecule inhibitors targeting various diseases. For instance, studies have demonstrated its utility in generating compounds with potential antiviral and anticancer properties. The fluorinated aromatic aldehydes derived from this precursor have shown promise in modulating enzyme activity and disrupting pathogenic processes.

The pharmaceutical industry has been particularly interested in leveraging the reactivity of 4-Chloro-3,5-difluorobenzaldehyde to develop next-generation drugs. Researchers have utilized palladium-catalyzed cross-coupling reactions to introduce additional functional groups onto the benzene ring, creating derivatives with enhanced pharmacological profiles. These efforts have led to the identification of several lead compounds that are currently undergoing preclinical evaluation.

Beyond pharmaceutical applications, 4-Chloro-3,5-difluorobenzaldehyde has found utility in the agrochemical sector as well. Its structural motifs are shared by several herbicides and fungicides that exhibit high efficacy against crop pathogens. The chlorine and fluorine substituents contribute to the stability and bioavailability of these agrochemicals, ensuring their effectiveness in field conditions.

The chemical properties of 4-Chloro-3,5-difluorobenzaldehyde also make it a valuable tool in organic synthesis. The aldehyde group can undergo condensation reactions with various nucleophiles, such as amines and hydrazines, to form Schiff bases and other heterocyclic compounds. These derivatives often exhibit interesting electronic properties and are explored for applications in catalysis and materials science.

Recent advances in green chemistry have prompted researchers to investigate more sustainable methods for synthesizing 4-Chloro-3,5-difluorobenzaldehyde. Catalytic processes that minimize waste and energy consumption are being developed to align with environmental regulations. Additionally, biocatalytic approaches using engineered enzymes have shown promise in improving yield and selectivity during production.

The biological activity of derivatives of 4-Chloro-3,5-difluorobenzaldehyde has been thoroughly investigated. In vitro studies have revealed that certain analogs exhibit inhibitory effects on enzymes involved in inflammatory pathways. These findings suggest potential therapeutic applications for treating chronic inflammatory diseases. Furthermore, animal models have been employed to assess the safety and efficacy of these compounds before they progress to human trials.

In conclusion, 4-Chloro-3,5-difluorobenzaldehyde (CAS No. 1160573-20-5) is a multifaceted compound with broad applications across pharmaceuticals, agrochemicals, and materials science. Its unique structural features enable diverse synthetic transformations and biological activities, making it a cornerstone in modern chemical research. As advancements continue to emerge in drug discovery and sustainable chemistry, the importance of this compound is expected to grow further.

• 90390-49-1(3-Chloro-5-fluorobenzaldehyde)
• 127675-46-1(3-Chloro-2,4-difluorobenzaldehyde)
• 34328-61-5(3-Chloro-4-fluorobenzaldehyde)
• 86522-91-0(2,4-Dichloro-5-fluorobenzaldehyde)
• 842140-45-8([1,1'-Biphenyl]-4-carboxaldehyde,4'-chloro-3'-fluoro-)
• 5527-95-7(4-Chloro-3-Fluorobenzaldehyde)
• 190011-87-1(3-Chloro-2,6-difluorobenzaldehyde)
• 879093-02-4(4-Chloro-2,5-difluorobenzaldehyde)
• 718628-28-5(4-(3-Chloro-4-fluorophenyl)benzaldehyde)
• 96516-31-3(2-Chloro-3-fluorobenzaldehyde)